QIAGEN (QGEN)
(Delayed Data from NYSE)
$49.95 USD
-0.30 (-0.60%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $49.93 -0.02 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth D Momentum B VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
QGEN 49.95 -0.30(-0.60%)
Will QGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for QGEN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for QGEN
Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say
Qiagen (QGEN) Matches Q2 Earnings Estimates
QGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
CERVOMED INC (CRVO) Surges 11.6%: Is This an Indication of Further Gains?
Why Qiagen (QGEN) is a Top Growth Stock for the Long-Term
Is Hologic Stock a Risky Investment Ahead of Its Q3 Earnings Report?
Other News for QGEN
Here are the major earnings after the close Tuesday
What to Expect from Qiagen NV (QGEN) Q2 2025 Earnings
Qiagen Non-GAAP EPS of $0.60 in-line, revenue of $534M beats by $9.98M
QIAGEN (QGEN) Exceeds Q2 Revenue Expectations, Prepares for New Launches
Earnings Scheduled For August 5, 2025